Orsolya Rideg

434 total citations
15 papers, 348 citations indexed

About

Orsolya Rideg is a scholar working on Surgery, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Orsolya Rideg has authored 15 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 6 papers in Molecular Biology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Orsolya Rideg's work include Antiplatelet Therapy and Cardiovascular Diseases (5 papers), Drug Transport and Resistance Mechanisms (3 papers) and Coronary Interventions and Diagnostics (3 papers). Orsolya Rideg is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (5 papers), Drug Transport and Resistance Mechanisms (3 papers) and Coronary Interventions and Diagnostics (3 papers). Orsolya Rideg collaborates with scholars based in Hungary, Netherlands and Italy. Orsolya Rideg's co-authors include Tamás Magyarlaki, Dániel Aradi, András Komócsi, Margit Tökés‐Füzesi, András Vorobcsuk, Iván Horváth, Victor L. Serebruany, Gábor L. Kovaćs, Attila Miseta and Attila Kónyi and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, American Heart Journal and European Journal of Clinical Investigation.

In The Last Decade

Orsolya Rideg

14 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Orsolya Rideg Hungary	9	246	152	75	46	42	15	348
Andrea Rivas United States	10	301 1.2×	152 1.0×	75 1.0×	18 0.4×	61 1.5×	20	375
François Donat France	8	226 0.9×	118 0.8×	135 1.8×	32 0.7×	41 1.0×	9	341
Julie K. Brooks United States	4	234 1.0×	89 0.6×	47 0.6×	10 0.2×	63 1.5×	6	326
Luciana Mucci Italy	7	244 1.0×	86 0.6×	82 1.1×	36 0.8×	81 1.9×	8	385
Haidar Maatouk Germany	7	324 1.3×	40 0.3×	245 3.3×	147 3.2×	39 0.9×	8	581
Ramón Brugada Spain	9	242 1.0×	55 0.4×	19 0.3×	84 1.8×	52 1.2×	17	329
Yanushi D. Wijeyeratne United Kingdom	7	159 0.6×	32 0.2×	27 0.4×	41 0.9×	10 0.2×	12	225
Murali Kodali United States	8	265 1.1×	99 0.7×	89 1.2×	9 0.2×	59 1.4×	12	310
Francesca Pagliaccia Italy	7	163 0.7×	67 0.4×	54 0.7×	65 1.4×	76 1.8×	10	314
Juan Muntaner Argentina	6	143 0.6×	48 0.3×	47 0.6×	24 0.5×	8 0.2×	13	240

Countries citing papers authored by Orsolya Rideg

Since Specialization

Citations

This map shows the geographic impact of Orsolya Rideg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Orsolya Rideg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Orsolya Rideg more than expected).

Fields of papers citing papers by Orsolya Rideg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Orsolya Rideg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Orsolya Rideg. The network helps show where Orsolya Rideg may publish in the future.

Co-authorship network of co-authors of Orsolya Rideg

This figure shows the co-authorship network connecting the top 25 collaborators of Orsolya Rideg. A scholar is included among the top collaborators of Orsolya Rideg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Orsolya Rideg. Orsolya Rideg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Rideg, Orsolya, et al.. (2022). High Prevalence of Non-Vaccinated Oncogenic Human Papillomavirus Genotypes in High-Grade Squamous Intraepithelial Lesions of the Cervix: Thought-Provoking Results of a Detailed HPV Genotype Analysis. Vaccines. 10(5). 748–748. 4 indexed citations

Rideg, Orsolya, et al.. (2021). Wide Spectrum Analysis of Human Papillomavirus Genotypes in External Anogenital Warts. Vaccines. 9(6). 604–604. 5 indexed citations

Tökés‐Füzesi, Margit, et al.. (2018). Role of microparticles derived from monocytes, endothelial cells and platelets in the exacerbation of COPD. International Journal of COPD. Volume 13. 3749–3757. 15 indexed citations

Grassi, Elisa, Gunnar Kleinau, Heike Biebermann, et al.. (2015). Loss-of-Function Variants in a Hungarian Cohort Reveal Structural Insights on TSH Receptor Maturation and Signaling. The Journal of Clinical Endocrinology & Metabolism. 100(7). E1039–E1045. 17 indexed citations

Rideg, Orsolya, Péter Osváth, S. Fekete, et al.. (2013). Patients with Difficult-to-Treat Depression Do not Exhibit an Increased Frequency of CYP2D6 Allele Duplication. Pharmacopsychiatry. 46(4). 156–160. 2 indexed citations

Aradi, Dániel, Orsolya Rideg, András Vorobcsuk, et al.. (2011). Justification of 150 mg clopidogrel in patients with high on‐clopidogrel platelet reactivity. European Journal of Clinical Investigation. 42(4). 384–392. 33 indexed citations

Aradi, Dániel, Orsolya Rideg, & András Komócsi. (2011). Platelet function monitoring in patients on clopidogrel. Interventional Medicine and Applied Science. 3(1). 32–38. 1 indexed citations

Rideg, Orsolya, András Komócsi, Tamás Magyarlaki, et al.. (2011). Impact of Genetic Variants on Post-Clopidogrel Platelet Reactivity in Patients After Elective Percutaneous Coronary Intervention. Pharmacogenomics. 12(9). 1269–1280. 46 indexed citations

Rideg, Orsolya, et al.. (2011). Pilot study for the characterization of pharmacogenetically relevantCYP2D6,CYP2C19andABCB1gene polymorphisms in the Hungarian population. Cell Biochemistry and Function. 29(7). 562–568. 17 indexed citations

10.

Aradi, Dániel, András Komócsi, András Vorobcsuk, et al.. (2010). Prognostic significance of high on-clopidogrel platelet reactivity after percutaneous coronary intervention: Systematic review and meta-analysis. American Heart Journal. 160(3). 543–551. 164 indexed citations

11.

Aradi, Dániel, Tamás Magyarlaki, Margit Tökés‐Füzesi, et al.. (2010). Comparison of conventional aggregomerty with VASP for monitoring P2Y12-specifc platelet inhibition. Platelets. 21(7). 563–570. 16 indexed citations

12.

Nagy, Tamás, András Rab, Orsolya Rideg, et al.. (2009). O-GlcNAc modification of proteins affects volume regulation in Jurkat cells. European Biophysics Journal. 39(8). 1207–1217. 9 indexed citations

13.

Magyarlaki, Tamás, Gábor Kovács, Ãgnes Nagy, et al.. (2008). Multidrug resistance in chronic lymphocytic leukemia. Orvosi Hetilap. 149(4). 161–167. 3 indexed citations

14.

Csutora, Péter, Árpád Karsai, Tamás Nagy, et al.. (2005). Lithium induces phosphoglucomutase activity in various tissues of rats and in bipolar patients. The International Journal of Neuropsychopharmacology. 9(5). 613–613. 15 indexed citations

15.

Rideg, Orsolya, Péter Csutora, Tamás Magyarlaki, et al.. (2005). [Multidrug resistance: diagnostic approaches and difficulties].. PubMed. 146(20). 995–1001. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact